Back to FMR LLC FMR LLC

REGNREGN
Showing 8 of 28 quarters

Position history for FMR LLCFMR LLC's holdings in Regeneron Pharmaceuticals, Inc.

Yes. FMR holds 831,964 shares of REGN (Regeneron Pharmaceuticals), worth $518.8M, as of its Q2 2026 13F filing. It reduced the position by 686,228 shares (-45.2%) from Q1 2026. FMR has held REGN in every 13F on record since Q3 2019, 28 quarterly filings.

Current Value

$518.8M

Current Shares

831,964

Total Value Change

-$10.4B

Total Shares Change

-9.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
831,964
-45.2%
$518.8M0.0%$622.81
0
2026-Q1
Decreased
1.5M
-34.5%
$1.2B0.1%$770.59
0
2025-Q4
Increased
2.3M
+19.8%
$1.8B0.1%$768.90
38
2025-Q3
Decreased
1.9M
-41.8%
$1.1B0.1%$559.40
0
2025-Q2
Decreased
3.3M
-56.2%
$1.7B0.1%$521.53
0
2025-Q1
Decreased
7.6M
-7.3%
$4.8B0.3%$629.11
0
2024-Q4
Decreased
8.2M
-20.9%
$5.8B0.3%$705.67
0
2024-Q3
Decreased
10.4M
-2.7%
$10.9B0.7%$1,041.41
0

Other major holders of REGN: VANGUARD GROUP INC, BlackRock, Inc., BlackRock Finance, Inc., JPMORGAN CHASE & CO

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used